Integrated physiology of proximal tubular organic anion transport

Current Opinion in Nephrology and Hypertension

Volumn 14, Issue 5, 2005, Pages 472-479

  Anzai, Naohiko ^a   Jutabha, Promsuk ^a   Kanai, Yoshikatsu ^a   Endou, Hitoshi ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Dicarboxylates; Multimolecular complex; Organic anion transporter; PDZ

Indexed keywords

MONOCARBOXYLATE TRANSPORTER; MULTIDRUG RESISTANCE PROTEIN 4; ORGANIC ANION TRANSPORTER; PDZ PROTEIN; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN ZO1;

ANIMAL CELL; ANION TRANSPORT; APICAL MEMBRANE; ATHEROSCLEROSIS; CONTROLLED STUDY; DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY PROXIMAL TUBULE; MEMBRANE TRANSPORT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEOMICS; RAT; RENOVASCULAR HYPERTENSION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; XENOPUS;

EID: 23844469535     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mnh.0000170751.56527.7e     Document Type: Review

References (57)

1. Miyazaki H, Sekine T, Endou H. The multispecific organic anion transporter family: properties and pharmacological significance. Trends Pharmacol Sci 2004; 25:654-662. This paper tracks the current progress of the OAT family from a pharmacological point of view.
2. Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 2004; 84:987-1049. This is an excellent review of the extensive physiological literature on the renal organic anion and cation transport systems.
3. You G. The role of organic ion transporters in drug disposition: an update. Curr Drug Metab 2004; 5:55-62.
4. Eraly SA, Bush KT, Sampogna RV, et al. The molecular pharmacology of organic anion transporters: from DNA to FDA? Mol Pharmacol 2004; 65:479-487. This is an intriguing review on several molecular aspects of the OAT family.
5. Koepsell H, Endou H. The SLC22 drug transporter family. Pflügers Arch 2004; 447:666-676. This is a standard general review of the organic cation/anion/zwitterions transporter family.
6. Bruckhardt BC, Bruckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 2003; 146:95-158.
7. Eraly SA, Blantz RC, Bhatnagar V, Nigam SK. Novel aspects of renal organic anion transporters. Curr Opin Nephrol Hypertens 2003; 12:551-558.
8. Russel FG, Masereeuw R, van Aubel RA. Molecular aspects of renal anionic drug transport. Annu Rev Physiol 2002; 64:563-594.
9. Anzai N, Enomoto A, Endou H. Renal urate handling: clinical relevance of recent advances. Curr Rheumatol Rep 2005; 7:227-234. This is a concise review focusing on the urate transport system in the kidneys.
10. Hediger MA, Johnson RJ, Miyazaki H, Endou H. Molecular physiology of urate transport. Physiology (Bethesda) 2005; 20:125-133. This is an extensive review on the urate transport including the physiological importance of urate in the body.
11. Rafey MA, Lipkowitz MS, Leal-Pinto E, Abramson RG. Uric acid transport. Curr Opin Nephrol Hypertens 2003; 12:511-516.
12. Cha SH, Sekine T, Kusuhara H, et al. Molecular cloning and characterization of multispecifc organic anion transporter 4 expressed in the placenta. J Biol Chem 2000; 275:4507-4512.
13. Ekaratanawong S, Anzai N, Jutabha P, et al. Human organic anion transporter 4 is a renal apical organic anion/dicarboxylate exchanger in the proximal tubules. J Pharmacol Sci 2004; 94:297-304. This paper provides the first description that apical OAT isoform functions as an organic anion/dicarboxylate exchanger.
14. Schmitt C, Burckhardt G. p-Aminohippurate/2-oxoglutarate exchange in bovine renal brush-border and basolateral membrane vesicles. Pfluegers Arch 1993; 423:280-290.
15. Youngblood GL, Sweet DH. Identification and functional assessment of the novel murine organic anion transporter Oat5 (Slc22a19) expressed in kidney. Am J Physiol Renal Physiol 2004; 287:F236-F244.
16. Hirata T, Jutabha P, Anzai N, et al. Characterization of a novel rat organic anion transporter OAT5 as an organic anion/dicarboxylate exchanger at the apical membrane of renal proximal tubules [abstract]. FASEB J 2004; 18:1250.
17. Sun W, Wu RR, van Poelje PD, Erion MD. Isolation of a family of organic anion transporters from human liver and kidney. Biochem Biophys Res Commun 2001; 283:417-422.
18. Enomoto A, Kimura H, Chairoungdua A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002; 417:447-452.
19. Hagenbuch B, Meier PJ. Organic anion transporting polypeptides of the OATP/SLC21 family: phylogenetic classification as OATP/SLCO superfamily, new nomenclature and molecular/functional properties. Pflugers Arch 2004; 447:653-665. This is a standard general review of the organic anion transporting family.
20. Mikkaichi T, Suzuki T, Tanemoto M, et al. The organic anion transporter (OATP) family. Drug Metab Pharmacokinet 2004; 19:171-179.
21. van Montfoort JE, Hagenbuch B, Groothuis GM, et al. Drug uptake systems in liver and kidney. Curr Drug Metab 2003; 4:185-211.
22. Masuda S. Functional characteristics and pharmacokinetic significance of kidney-specific organic anion transporters, OAT-K1 and OAT-K2, in the urinary excretion of anionic drugs. Drug Metab Pharmacokinet 2003; 18:91-103.
23. Mikkaichi T, Suzuki T, Onogawa T, et al. Isolation and characterization of a digoxin transporter and its rat homologue expressed in the kidney. Proc Natl Acad Sci U S A 2004; 101:3569-3574. This paper provides evidence that human OATP4C1 is a renal digoxin transporter.
24. Reimer RJ, Edwards RH. Organic anion transport is the primary function of the SLC17/type I phosphate transporter family. Pflugers Arch 2004; 447:629-635. This is a standard general review of the vesicular glutamate transporter family.
25. Uchino H, Tamai I, Yamashita K, et al. p-Aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1. Biochem Biophys Res Commun 2000; 270:254-259.
26. Jutabha P, Kanai Y, Hosoyamada M, et al. Identification of a novel voltage-driven organic anion transporter present at apical membrane of renal proximal tubule. J Biol Chem 2003; 278:27930-27938.
27. Kruh GD, Belinsky MG. The MRP family of drug efflux pumps. Oncogene 2003; 22:7537-7552.
28. van Aubel RA, Smeets PH, Peters JG, et al. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J Am Soc Nephrol 2002; 13:595-603.
29. Smeets PH, van Aubel RA, Wouterse AC, et al. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter. J Am Soc Nephrol 2004; 15:2828-2835. This paper provides evidence that human MRP4 is a renal PAH transporter.
30. van Aubel RA, Smeets PH, van den Heuvel JJ, Russel FG. Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites. Am J Physiol Renal Physiol 2005; 288:F327-F333. This paper provides evidence that human MRP4 is a renal urate transporter.
31. Roch-Ramel F, Werner D, Guisan B. Urate transport in brush-border membrane of human kidney. Am J Physiol Renal Physiol 1994; 266:F797-F805.
32. Miyauchi S, Gopal E, Fei YJ, Ganapathy V. Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids. J Biol Chem 2004; 279:13293-13296.
33. Gopal E, Fei YJ, Sugawara M, et al. Expression of slc5a8 in kidney and its role in Na(+)-coupled transport of lactate. J Biol Chem 2004; 279:44522-44532. This paper describes the functional characteristics of the sodium-glucose cotransporter family member SLC5A8.
34. Gopal E, Fei YJ, Miyauchi S, et al. Sodium-coupled and electrogenic transport of B-complex vitamin nicotinic acid by slc5a8, a member of the Na/glucose co-transporter gene family. Biochem J 2005; 388:309-316. This paper describes the functional characteristics of the sodium-glucose cotransporter family member SLC5A8.
35. Ganapathy V, Gopal E, Miyauchi S, Prasad PD. Biological functions of SLC5A8, a candidate tumour suppressor. Biochem Soc Trans 2005; 33:237-240. This paper describes the functional characteristics of the sodium-glucose cotransporter family member SLC5A8.
36. Zandi-Nejad K, Plata C, Enck AH, et al. Slc5a8 functions as a sodium-dependent pyrazionate and nicotinate cotransporter: implications for renal urate transport [abstract]. J Am Soc Nephrol 2004; 15:89A.
37. Hung AY, Sheng M. PDZ domains: structural modules for protein complex assembly. J Biol Chem 2002; 277:5699-5702.
38. Brone B, Eggermont J. PDZ proteins retain and regulate membrane transporters in polarized epithelial cell membranes. Am J Physiol Cell Physiol 2005; 288:C20-C29. This is an excellent and comprehensive review of the importance of PDZ interaction in the epithelial cells.
39. Hernando N, Wagner CA, Gisler SM, et al. PDZ proteins and proximal ion transport. Curr Opin Nephrol Hypertens 2004; 13:569-574. This is an excellent and concise review of the importance of PDZ interaction in the proximal tubular cells.
40. Biber J, Gisler SM, Hernando N, et al. PDZ interactions and proximal tubular phosphate reabsorption. Am J Physiol Renal Physiol 2004; 287:F871-F875.
41. Ichida K, Hosoyamada M, Hisatome I, et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan: influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004; 15:164-173.
42. Anzai N, Miyazaki H, Noshiro R, et al. The multivalent PDZ domain-containing protein PDZK1 regulates transport activity of renal urate-anion exchanger URAT1 via its C-terminal. J Biol Chem 2004; 279:45942-45950. This study describes, for the first time, the interaction of OAT family members (URAT1 and OAT4) with the PDZ domain protein PDZK1 and its functional consequences.
43. Miyazaki H, Anzai N, Jutabha P, et al. Transport mechanisms of a renal apical drug transporter, organic anion transporter 4 [abstract]. J Pharmacol Sci 2004; 94:112P.
44. Anzai N, Noshiro R, Miyazaki H, et al. Identification of the intracellular binding protein with proton-coupled oligopeptide transporter PEPT2 using yeast two-hybrid assay [abstract]. FASEB J 2004; 18:A695.
45. Hosoyamada M, Ichida K, Enomoto A, et al. Function and localization of urate transporter 1 in mouse kidney. J Am Soc Nephrol 2004; 15:261-268.
46. Gisler SM, Pribanic S, Bacic D, et al. PDZK1. I: A major scaffolder in brush borders of proximal tubular cells. Kidney Int 2003; 64:1733-1745.
47. Gisler SM, Madjdpour C, Bacic D, et al. PDZK1. II: An anchoring site for the PKA-binding protein D-AKAP2 in renal proximal tubular cells. Kidney Int 2003; 64:1746-1754.
48. Kato Y, Yoshida K, Watanabe C, et al. Screening of the interaction between xenobiotic transporters and PDZ proteins. Pharm Res 2004; 21:1886-1894.
49. Moe OW. Scaffolds: orchestrating proteins to achieve concerted function. Kidney Int 2003; 64:1916-1917.
50. + exchanger regulating factor 2, serum and glucocorticoid inducible kinase isoforms, and protein kinase B. Biochem Biophys Res Commun 2004; 313:998-1003.
51. He W, Miao FJ, Lin DC, et al. Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors. Nature 2004; 429:188-193. This paper provides evidence that GPR91 and GPR99 are expressed in the kidneys and function as dicarboxylate receptors.
52. Ishikawa T, Tsuji A, Inui K, et al. The genetic polymorphism of drug transporters: functional analysis approaches. Pharmacogenomics 2004; 5:67-99. This review emphasizes drug transporter SNPs as a determinant of inter-individual differences in drug response.
53. Marzolini C, Tirana RG, Kim RB. Pharmacogenomics of the OATP and OAT families. Pharmacogenomics 2004; 5:273-282.
54. +/ peptide cotransporter 2 causes a complete loss of transport function. Biochem Biophys Res Commun 2004; 316:416-420. This paper provides the first description about the altered function of PEPT2 SNPs.
55. Fujita T, Brown C, Carlson EJ, et al. Functional analysis of polymorphisms in the organic anion transporter, SLC22A6 (OAT1). Pharmacogenet Genomics 2005; 15:201-209. This paper provides the first description of the altered function of OAT1 SNPs.
56. Anzai N, Miyazaki H, Hirata T, et al. Regulation of renal urate transporter URAT1 transport function by PDZ domain protein PDZK1 [abstract]. J Pharmacol Sci 2005; 97:120P.
57. Yokoyama H, Anzai N, Chaekuntode S, et al. Identification of a novel organic anion transporter OAT8 from the rat kidney [abstract]. Nephrol Dial Transpl 2003; 18:S8.